[{"id":"501a5153-229c-4cfc-a5b1-b378aed3cb21","acronym":"","url":"https://clinicaltrials.gov/study/NCT04533321","created_at":"2021-01-18T21:42:00.367Z","updated_at":"2024-07-02T16:36:41.549Z","phase":"Phase 2","brief_title":"A Biomarker-implemented Clinical Study Evaluating Mutations in MET and TP53 in a Population of Treatment-refractory Squamous Cell Carcinoma","source_id_and_acronym":"NCT04533321","lead_sponsor":"National University Hospital, Singapore","biomarkers":" TP53 • MET","pipe":" | ","alterations":" TP53 mutation • HER-2 amplification • MET amplification • MET mutation • MET N375S • HER-2 amplification + MET amplification","tags":["TP53 • MET"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TP53 mutation • HER-2 amplification • MET amplification • MET mutation • MET N375S • HER-2 amplification + MET amplification"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Gilotrif (afatinib)"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 20","initiation":"Initiation: 09/01/2020","start_date":" 09/01/2020","primary_txt":" Primary completion: 09/01/2023","primary_completion_date":" 09/01/2023","study_txt":" Completion: 09/01/2023","study_completion_date":" 09/01/2023","last_update_posted":"2020-08-31"},{"id":"58329fe3-7b53-425e-aef4-7c42903badc1","acronym":"","url":"https://clinicaltrials.gov/study/NCT03938012","created_at":"2021-01-17T18:04:15.317Z","updated_at":"2024-07-02T16:36:59.909Z","phase":"","brief_title":"Evaluating Mutations in MET and TP53 Among Patients Diagnosed With Squamous Cell Carcinoma","source_id_and_acronym":"NCT03938012","lead_sponsor":"National University Hospital, Singapore","biomarkers":" TP53 • MET","pipe":" | ","alterations":" TP53 mutation • HER-2 amplification • MET amplification • MET mutation • MET N375S • HER-2 amplification + MET amplification","tags":["TP53 • MET"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TP53 mutation • HER-2 amplification • MET amplification • MET mutation • MET N375S • HER-2 amplification + MET amplification"],"overall_status":"Recruiting","enrollment":" Enrollment 80","initiation":"Initiation: 10/03/2017","start_date":" 10/03/2017","primary_txt":" Primary completion: 10/01/2021","primary_completion_date":" 10/01/2021","study_txt":" Completion: 10/01/2022","study_completion_date":" 10/01/2022","last_update_posted":"2019-05-06"}]